1.57
+0.8833(+128.95%)
Currency In USD
| Previous Close | 0.69 |
| Open | 1.22 |
| Day High | 1.39 |
| Day Low | 0.98 |
| 52-Week High | 6 |
| 52-Week Low | 0.62 |
| Volume | 169.12M |
| Average Volume | 123,352 |
| Market Cap | 16.63M |
| PE | -0.52 |
| EPS | -2.26 |
| Moving Average 50 Days | 0.92 |
| Moving Average 200 Days | 2.17 |
| Change | 0.48 |
If you invested $1000 in Firefly Neuroscience, Inc. (AIFF) 10 years ago, it would be worth $299.97 as of March 04, 2026 at a share price of $1.17. Whereas If you bought $1000 worth of Firefly Neuroscience, Inc. (AIFF) shares 5 years ago, it would be worth $17.18 as of March 04, 2026 at a share price of $1.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
Newsfile
Mar 06, 2025 12:30 PM GMT
A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementiaCalgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: